Department of Anaesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Department of Anaesthesiology, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Anaesth Crit Care Pain Med. 2022 Aug;41(4):101108. doi: 10.1016/j.accpm.2022.101108. Epub 2022 May 27.
The present study was designed to compare the intubating conditions of rocuronium giving by "a modified timing principle" in rapid induction and intubation (RSII) with that of the gold standard, succinylcholine. One hundred and twenty-four patients were randomly divided into rocuronium group (group R, n = 62) or succinylcholine group (group S, n = 62). In group R, after rocuronium 0.6 mg kg was given, anaesthesia was induced with propofol 2 mg kg and remifentanil 2 μg kg, and tracheal intubation was performed 60 sec after rocuronium administration. In group S, succinylcholine 1.5 mg kg was given after patient lost consciousness induced by the same regimen of group R, and tracheal intubation was performed 60 sec after succinylcholine administration. Our primary endpoint was the intubating conditions. The numbers of patients with excellent and good intubating conditions in group R were 90.0% and 6.7%, respectively, which were comparable with those in group S (91.7% and 5.0% respectively). The apnoea time in group S (79.7 ± 5.1 sec) was longer than that of group R (56.6 ± 4.6 sec) (p = 0.0063). The average BIS values at the time of intubation in group R (64.1 ± 4.1) was higher than that of group S (43.2 ± 5.5) (p = 0.018). In the context of a RSII with lidocaine-remifentanil-propofol, the application of this "modified timing principle" with rocuronium 0.6 mg kg could provide comparable intubating conditions with those achieved by succinylcholine 1.5 mg kg. Additionally, this modified timing principle with rocuronium was associated with shorter apnoea time.
本研究旨在比较罗库溴铵在快速诱导和插管(RSII)中“改良时间原则”给药与琥珀胆碱的插管条件。124 名患者随机分为罗库溴铵组(R 组,n=62)或琥珀胆碱组(S 组,n=62)。R 组患者给予罗库溴铵 0.6mg/kg 后,用丙泊酚 2mg/kg 和瑞芬太尼 2μg/kg 诱导麻醉,罗库溴铵给药后 60s 行气管插管。S 组患者在接受与 R 组相同方案诱导意识丧失后给予琥珀胆碱 1.5mg/kg,琥珀胆碱给药后 60s 行气管插管。主要终点是插管条件。R 组患者插管条件优和良的例数分别为 90.0%和 6.7%,与 S 组(分别为 91.7%和 5.0%)相当。S 组的无通气时间(79.7±5.1s)长于 R 组(56.6±4.6s)(p=0.0063)。R 组插管时平均 BIS 值(64.1±4.1)高于 S 组(43.2±5.5)(p=0.018)。在利多卡因-瑞芬太尼-丙泊酚的 RSII 背景下,应用 0.6mg/kg 罗库溴铵的这种“改良时间原则”可提供与 1.5mg/kg 琥珀胆碱相似的插管条件。此外,这种改良的罗库溴铵时间原则与较短的无通气时间相关。